Skip Navigation


Human Molecular Genetics Advance Access originally published online on June 29, 2005
Human Molecular Genetics 2005 14(15):2265-2276; doi:10.1093/hmg/ddi231
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
14/15/2265    most recent
ddi231v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Davis-Silberman, N.
Right arrow Articles by Ashery-Padan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis-Silberman, N.
Right arrow Articles by Ashery-Padan, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Genetic dissection of Pax6 dosage requirements in the developing mouse eye

Noa Davis-Silberman1, Tomer Kalich1, Varda Oron-Karni1, Till Marquardt2, Markus Kroeber3, Ernst R. Tamm3 and Ruth Ashery-Padan1,*

1Sackler Faculty of Medicine, Department of Human Genetics and Molecular Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel, 2The Salk Institute for Biological Studies, Gene Expression Laboratory, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA and 3Department of Human Anatomy, University of Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany

* To whom correspondence should be addressed. Tel: +972 36409331; Fax: +972 36409900; Email: ruthash{at}post.tau.ac.il

Received March 9, 2005; Revised June 10, 2005; Accepted June 23, 2005

Haploinsufficiency of the transcription factor Pax6/PAX6 has been implicated in a number of congenital eye disorders in humans and mice, such as aniridia and Small-eye, which affect the development and function of the lens, cornea, anterior eye segment and neuroretina. However, the widespread distribution of Pax6/PAX6 protein within the developing and adult eye preclude the identification and direct study of the ocular tissues affected by a reduction in Pax6/PAX6 dosage. Here, we employed Cre/loxP-mediated inactivation of a single Pax6 allele in either the lens/cornea or the distal optic cup to dissect the tissue-specific sensitivity to Pax6 haploinsufficiency. Exclusive inactivation of a single Pax6 allele in the lens recapitulates the Small-eye lens and corneal defects, while only mildly affects iris morphology in a non-cell-autonomous fashion. Conversely, selective inactivation of a single Pax6 allele in the distal optic cup revealed primarily cell-autonomous dosage requirements for proper iris differentiation, with no affects on either lens or corneal morphology. Pax6 dosage within the distal optic cup is found here to influence the number of progenitors destined for the anterior ocular structures, the timing of iris muscle-cell differentiation and iris stroma development. Taken together, we genetically dissected the complex mouse Small-eye phenotype, thereby pinpointing the underlying Pax6/PAX6 haploinsufficiency to autonomous dosage requirements within the developing iris and lens/cornea tissues.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
Y. Chen, Y.-q. Doughman, S. Gu, A. Jarrell, S.-i. Aota, A. Cvekl, M. Watanabe, S. L. Dunwoodie, R. S. Johnson, V. van Heyningen, et al.
Cited2 is required for the proper formation of the hyaloid vasculature and for lens morphogenesis
Development, September 1, 2008; 135(17): 2939 - 2948.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. Favor, C. J. Gloeckner, A. Neuhauser-Klaus, W. Pretsch, R. Sandulache, S. Saule, and I. Zaus
Relationship of Pax6 Activity Levels to the Extent of Eye Development in the Mouse, Mus musculus
Genetics, July 1, 2008; 179(3): 1345 - 1355.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
S. Kanakubo, T. Nomura, K.-i. Yamamura, J.-i. Miyazaki, M. Tamai, and N. Osumi
Abnormal migration and distribution of neural crest cells in Pax6 heterozygous mutant eye, a model for human eye diseases.
Genes Cells, August 1, 2006; 11(8): 919 - 933.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Zhou, E. F. Rappaport, J. W. Tobias, and T. L. Young
Differential Gene Expression in Mouse Sclera during Ocular Development
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1794 - 1802.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.